ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,180.74
1.03%
US Tech 100
17,600.40
1.04%
다우존스 지수
38,852.27
0.46%
Bitcoin
63,393.46
-0.95%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Immunome Inc (IMNM)

  7. Immunome Inc (IMNM) 뉴스

IMNM Immunome Inc

15.46
-0.29 (-1.84%)
시간외 거래
최종 업데이트: 05:00:04
15분 지연
기업명 주식 심볼 시장 주식 타입
Immunome Inc IMNM 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.29 -1.84% 15.46 05:00:04
개장가 저가 고가 종가 전일 종가
15.75 15.12 16.1799 15.46 15.75
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202421:00BWImmunome Appoints Kinney Horn as Chief Business Officer
25/04/202421:26BWImmunome Appoints Sandra M. Swain to Board of Directors
05/04/202421:00BWImmunome to Present Preclinical Data for IM-3050, Its Lead..
29/03/202405:02BWImmunome Reports Full Year 2023 Financial Results and..
26/03/202421:00BWImmunome Completes Acquisition of AL102, a Phase 3 Asset for..
07/03/202422:00BWImmunome to Participate in the Leerink Partners Global..
01/03/202422:00BWImmunome to Participate in the TD Cowen 44th Annual..
22/02/202411:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
20/02/202422:15BWImmunome Recognizes Ayala Pharmaceuticals’ Announced..
17/02/202406:05BWImmunome Announces Closing of Public Offering and Full..
15/02/202406:11EDGAR2Form 8-K - Current report
15/02/202406:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/02/202412:38BWImmunome Announces Pricing of Public Offering of Common..
14/02/202406:36EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/02/202406:10EDGAR2Form 8-K - Current report
14/02/202406:05BWImmunome Announces Proposed Public Offering of Common Stock
13/02/202404:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202422:05EDGAR2Form 8-K - Current report
05/02/202422:00BWImmunome to Present at the Guggenheim Healthcare Talks 6th..
03/02/202406:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/02/202410:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202410:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202407:27EDGAR2Form 8-K - Current report
08/01/202421:05EDGAR2Form 8-K - Current report
08/01/202421:00BWImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug..
05/01/202407:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/01/202422:00BWImmunome Appoints Phil Roberts as Chief Technical Officer
03/01/202422:00BWImmunome to Present at the 42nd Annual J.P. Morgan..
02/01/202422:05EDGAR2Form 8-K - Current report
02/01/202422:00BWImmunome Appoints Carol A. Schafer to Board of Directors
30/12/202307:00EDGAR2Form 8-K - Current report
26/12/202322:35EDGAR2Form 8-K - Current report
26/12/202322:30GLOBEAtreca Announces Asset Purchase Agreement for Sale of..
16/12/202309:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202311:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
23/11/202306:02EDGAR2Form 8-K/A - Current report: [Amend]
17/11/202306:08EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202320:03EDGAR2Form 8-K - Current report
10/11/202322:00BWImmunome to Present at the Stifel 2023 Healthcare Conference
10/11/202306:52EDGAR2Form 8-K - Current report
09/11/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:00BWImmunome Reports Third Quarter 2023 Financial Results
08/11/202322:30EDGAR2Form 8-K - Current report
08/11/202322:00BWImmunome Appoints Jean-Jacques Bienaimé to Board of..
01/11/202307:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202307:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202321:00BWImmunome Appoints Bob Lechleider, M.D., as Chief Medical..

최근 히스토리

NASDAQ
IMNM
Immunome
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유